Nr Saffron Walden, United Kingdom

Wouter Meuleman

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Nr Saffron Walden, GB (2019 - 2022)
  • San Diego, CA (US) (2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Wouter Meuleman: Innovator in Nucleic Acid Technologies

Introduction

Wouter Meuleman is a prominent inventor based in Nr Saffron Walden, GB. He has made significant contributions to the field of nucleic acid technologies, holding a total of 4 patents. His work focuses on innovative methods and compositions that enhance the understanding and manipulation of genetic materials.

Latest Patents

Among his latest patents, the "Contiguity Preserving Transposition" stands out. This invention relates to methods and compositions for preparing an immobilized library of barcoded DNA fragments of a target nucleic acid. It also involves identifying genomic variants and determining the contiguity information, phasing information, and methylation status of the target nucleic acid. Another notable patent is the "Pyrophosphorolytic Sequencing," which outlines a method for determining the sequence of a target nucleic acid. This method includes steps of contacting a target nucleic acid with a polymerase to sequentially remove nucleotide triphosphates, distinguishing the different base moieties for the nucleotide triphosphates that are removed.

Career Highlights

Wouter Meuleman is currently associated with Illumina Cambridge Limited, a leading company in the field of genomics. His work at Illumina has allowed him to push the boundaries of nucleic acid research and technology.

Collaborations

Throughout his career, Wouter has collaborated with notable colleagues such as Rosamond Jackson and Elena Cressina. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Wouter Meuleman is a key figure in the realm of nucleic acid technologies, with a focus on innovative methods that enhance genetic research. His contributions through patents and collaborations continue to shape the future of genomics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…